TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer.

A Poveda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.